Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers Results available

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

ClinicalTrials.gov ID: NCT04925752

Public ClinicalTrials.gov record NCT04925752. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People ≥ 16 Years of Age Who Have Sex With Male Partners and Are at Risk for HIV Infection

Study identification

NCT ID
NCT04925752
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
3,292 participants

Conditions and interventions

Interventions

  • Oral Lenacapavir (LEN) Drug
  • F/TDF Drug
  • Sub-cutaneous (SC) Lenacapavir (LEN) Drug
  • Placebo SC LEN Drug
  • PTM F/TDF Drug
  • PTM Oral LEN Drug
  • F/TAF (for US participants only) Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2021
Primary completion
Aug 20, 2024
Completion
Jul 31, 2028
Last update posted
Dec 22, 2025

2021 – 2028

United States locations

U.S. sites
60
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
UAB Sexual Health Research Clinic Birmingham Alabama 35233
Loma Linda University Clinical Trial Center Clinic Loma Linda California 92354
Ruane Clinical Research Group Inc. Los Angeles California 90036
UCLA CBAM Vine Street Clinic Los Angeles California 90038
Charles R. Drew University of Medicine and Science (CDU) - Clinical Translational Research Center (CTRC) Los Angeles California 90059
Mills Clinical Research Los Angeles California 90069
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Los Angeles California 90502
BIOS Clinical Research Palm Springs California 92262
UCSD Anti Viral Research Center San Diego California 92103
Bridge HIV at the San Francisco Department of Public Health San Francisco California 94102
Optimus Medical Group San Francisco California 94102
University of Colorado Clinical and Translational Research Centers (CTRC) Aurora Colorado 80045
Yale University, School of Medicine New Haven Connecticut 06510
Whitman-Walker Institute Inc. Washington D.C. District of Columbia 20009
Washington Health Institute Washington D.C. District of Columbia 20017
Therafirst Medical Center Fort Lauderdale Florida 33308
Gary Richmond, MD, PA Fort Lauderdale Florida 33316
Midway Immunology & Research Center, LLC Ft. Pierce Florida 34982
CAN Community Health Clinic Jacksonville Florida 32207
University of Miami Miller School of Medicine Division of Infectious Disease Research - Converge Miami Miami Florida 33136
CAN Community Health Miami Gardens Florida 33055
Orlando Immunology Center Orlando Florida 32803
CAN Community Health Sarasota Florida 34237
The Hope Clinic at Emory University Atlanta Georgia 30030
Emory University Atlanta Georgia 30303
Emory University Hospital Midtown Infectious Disease Clinic Atlanta Georgia 30308
RMR Core Center Chicago Illinois 60612
University of Illinois at Chicago, Department of Medicine, Division of Infectious Diseases, Project WISH Chicago Illinois 60612
Howard Brown Health Center Chicago Illinois 60613
Indiana University Infectious Diseases Research Indianapolis Indiana 46202
Baptist Health Lexington Lexington Kentucky 40503
Norton Infectious Disease Specialists Louisville Kentucky 40241
LSU-CrescentCare Sexual Health Center- New Orleans Community Health Center New Orleans Louisiana 70119
Johns Hopkins University School of Medicine Baltimore Maryland 21287
The Fenway Institute Boston Massachusetts 02215
Be Well Medical Center Berkley Michigan 48072
Henry Ford Hospital Detroit Michigan 48202
Open Arms Healthcare Center Jackson Mississippi 39202
KC CARE Health Center Kansas City Missouri 64111
St. Michael's Medical Center Newark New Jersey 07102
South Jersey Infectious Disease Somers Point New Jersey 08244
Icahn School of Medicine at Mount Sinai- Mount Sinai Downtown New York New York 10029
NC TraCS Institute - CTRC; University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514
Cone Health/Regional Center for Infectious Disease Research Center Greensboro North Carolina 27401
Wake Forest University Health Sciences Winston-Salem North Carolina 27103
University of Cincinnati Cincinnati Ohio 45267
The Ohio State University Wexner Medical Center Columbus Ohio 43210
Penn Prevention Unit Philadelphia Pennsylvania 19104
Philadelphia FIGHT Community Health Centers, Jonathan Lax Treatment Center Philadelphia Pennsylvania 19107
Medical University of South Carolina, Infectious Disease Clinic Charleston South Carolina 29425
Prisma Health-Midlands Clinical Research Unit Columbia South Carolina 29203
Prisma Health Internal Medicine Clinic Greenville South Carolina 29605
Methodist University Hospital/University of Tennessee Health Science Center, Clinical Research Center Memphis Tennessee 38103
St Jude Children's Research Hospital Memphis Tennessee 38105
Meharry Medical College Clinical and Transitional Research Center Nashville Tennessee 37208
Central Texas Clinical Research Austin Texas 78705
Centro San Vincente El Paso Texas 79915
UT Health Science Center at Houston Houston Texas 77009
The Crofoot Research Center, INC Houston Texas 77098
Ofiice of Dr. Peter Shalit, MD Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04925752, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04925752 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →